Announcement from Guangdong Jiaying Pharmaceutical: The operating revenue in the first half of 2024 was 0.18 billion yuan, a decrease of 30% compared to the same period last year; the net income attributable to shareholders of the listed company was 5.6677 million yuan, a decrease of 68.94% compared to the same period last year.
嘉应制药：2024上半年净利润下降68.94%
Guangdong Jiaying Pharmaceutical: The net income in the first half of 2024 decreased by 68.94%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated